The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, Z., Banerjee, S., Li, Y., Rahman, K. M. W., Zhang, Y., & Sarkar, F. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4281 · Cited by 307
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Self-citationNF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Introduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,222
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 1×
“In addition, STAT3 levels are elevated in a number of human cancers, including breast cancer, prostate cancer, head and neck cancers, and hematologic malignancies (Bowman et al., 2000).”
BackgroundCatlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Self-citationMaeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Self-citationCYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
Hu, M. C.-T., Lee, D.-F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J.-Y., Zou, Y., Bao, S., Hanada, N., Saso, H., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00302-2 · Cited by 868
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
PI 3-kinase, Akt and cell survival
Downward, J. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.01.002 · Cited by 783
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202445099 · Cited by 741
Role of NF-κB in p53-mediated programmed cell death
Ryan, K. M., Ernst, M. K., Rice, N. R., & Vousden, K. H. (2000) · Nature · doi:10.1038/35009130 · Cited by 740
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Chauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694 · cited 1×
“A newly developed proteasome inhibitor, NPI0052, with properties distinct from bortezomib, also induces the death of multiple myeloma cells (Chauhan et al., 2005).”
BackgroundJung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N. C., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.12.4525 · Cited by 669
IκB kinase complexes: gateways to NF-κB activation and transcription
Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 651
Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.-C., Wulf, G., Rottapel, R., Yamaoka, S., & Lu, K. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00490-8 · Cited by 637
A loss-of-function RNA interference screen for molecular targets in cancer
Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., et al. (2006) · Nature · doi:10.1038/nature04687 · Cited by 605
Transcriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598
Inhibitors of NF-κB signaling: 785 and counting
Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 569
NF-κB as a therapeutic target in cancer
Orlowski, R. Z., & Baldwin, A. S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02375-4 · Cited by 553
Self-citationNF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras
Mayo, M. W., Wang, C.-Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., & Baldwin, A. S. (1997) · Science · doi:10.1126/science.278.5344.1812 · Cited by 533
Self-citationMutations in the NF-κB signaling pathway: implications for human disease
Courtois, G., & Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209939 · Cited by 525
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity
Keifer, J. A., Guttridge, D. C., Ashburner, B. P., & Jr.Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100938200 · Cited by 478
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
Shishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459
Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
Self-citationNF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
Biswas, D. K., Shi, Q., Baily, S., Strickland, I., Ghosh, S., Pardee, A. B., & Iglehart, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403621101 · Cited by 447
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., & Aggarwal, B. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204997 · Cited by 441
Anto, R. J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.143 · Cited by 429
Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., & Baltimore, D. (1993) · Genes & Development · doi:10.1101/gad.7.7b.1354 · Cited by 409
Current insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 407
Bubici, C., Papa, S., Dean, K., & Franzoso, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209936 · Cited by 399
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
NF-κB and IKK as therapeutic targets in cancer
Kim, H. J., Hawke, N., & Baldwin, A. S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401877 · Cited by 391
Self-citationTranscription factor cross-talk: the estrogen receptor and NF-κB
Kalaitzidis, D., & Gilmore, T. D. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.01.004 · Cited by 388
Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Campbell, K. J., Rocha, S., & Perkins, N. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00131-5 · Cited by 386
Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., & Baldwin, A. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24113 · Cited by 375
Self-citationHuang, S., Mills, L., Mian, B., Tellez, C., McCarty, M., Yang, X.-D., Gudas, J. M., & Bar-Eli, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64164-8 · Cited by 361
Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8542 · Cited by 351
Ougolkov, A. V., Fernandez-Zapico, M. E., Savoy, D. N., Urrutia, R. A., & Billadeau, D. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3642 · Cited by 327
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Russo, S. M., Tepper, J. E., Baldwin, A. S., Liu, R., Adams, J., Elliott, P., & Cusack, J. C. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01446-8 · Cited by 318
Self-citationp53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 310
Asano, T., Yao, Y., Zhu, J., Li, D., Abbruzzese, J. L., & Reddy, S. A. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207902 · Cited by 303
Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes
Kim, J. H., Kim, B., Cai, L., Choi, H. J., Ohgi, K. A., Tran, C., Chen, C., Chung, C. H., Huber, O., Rose, D. W., et al. (2005) · Nature · doi:10.1038/nature03452 · Cited by 291
Grandage, V. L., Gale, R. E., Linch, D. C., & Khwaja, A. (2005) · Leukemia · doi:10.1038/sj.leu.2403653 · Cited by 281
Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells
Furman, R. R., Asgary, Z., Mascarenhas, J. O., Liou, H.-C., & Schattner, E. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2200 · Cited by 278
A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells
Dhawan, P., & Richmond, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112210200 · Cited by 267
Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R. J., & Sonenshein, G. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204257 · Cited by 265
Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells
Kordes, U., Krappmann, D., Heissmeyer, V, Ludwig, W., & Scheidereit, C. (2000) · Leukemia · doi:10.1038/sj.leu.2401705 · Cited by 264
Hinz, M., Löser, P., Mathas, S., Krappmann, D., Dörken, B., & Scheidereit, C. (2001) · Blood · doi:10.1182/blood.v97.9.2798 · Cited by 261
NF-κB: tumor promoter or suppressor?
Perkins, N. D. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.12.004 · Cited by 261
Heppner, C., Bilimoria, K. Y., Agarwal, S. K., Kester, M., Whitty, L. J., Guru, S. C., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Marx, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204529 · Cited by 257
Müerköster, S., Wegehenkel, K., Arlt, A., Witt, M., Sipos, B., Kruse, M.-L., Sebens, T., Klöppel, G., Kalthoff, H., Fölsch, U. R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1860 · Cited by 254
Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses
Hiscott, J., Nguyen, T.-L. A., Arguello, M., Nakhaei, P., & Paz, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209941 · Cited by 247
Positive and negative regulation of EAAT2 by NF‐κB: a role for N‐myc in TNFα‐controlled repression
Sitcheran, R., Gupta, P., Fisher, P. B., & Baldwin, A. S. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600555 · Cited by 240
Self-citationYin, D., Zhou, H., Kumagai, T., Liu, G., Ong, J. M., Black, K. L., & Koeffler, H. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208225 · Cited by 232
Lam, L. T., Davis, R. E., Pierce, J., Hepperle, M., Xu, Y., Hottelet, M., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.28.11.1 · Cited by 229
Nuclear factor-κB: a friend or a foe in cancer?
Shishodia, S., & Aggarwal, B. B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.026 · Cited by 228
Fernández, Y., Verhaegen, M., Miller, T. P., Rush, J. L., Steiner, P., Opipari, A. W., Lowe, S. W., & Soengas, M. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0686 · Cited by 222
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis
Fernandez-Zapico, M. E., Gonzalez-Paz, N. C., Weiss, E., Savoy, D. N., Molina, J. R., Fonseca, R., Smyrk, T. C., Chari, S. T., Urrutia, R., & Billadeau, D. D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.024 · Cited by 221
Landowski, T. H., Megli, C. J., Nullmeyer, K. D., Lynch, R. M., & Dorr, R. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3684 · Cited by 202
Gustin, J. A., Ozes, O. N., Akca, H., Pincheira, R., Mayo, L. D., Li, Q., Guzman, J. R., Korgaonkar, C. K., & Donner, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306976200 · Cited by 199
Shishodia, S., Koul, D., & Aggarwal, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2011 · Cited by 185
The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition
Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L., & Baldwin, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8428-8436.2001 · Cited by 182
Self-citationInhibition of NF-κB essentially contributes to arsenic-induced apoptosis
Mathas, S., Lietz, A., Janz, M., Hinz, M., Jundt, F., Scheidereit, C., Bommert, K., & Dörken, B. (2003) · Blood · doi:10.1182/blood-2002-04-1154 · Cited by 174
Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancer
Liptay, S., Weber, C. K., Ludwig, L., Wagner, M., Adler, G., & Schmid, R. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11081 · Cited by 172
Epithelial-Mesenchymal Transition: NF-κB Takes Center Stage
Huber, M. A., Beug, H., & Wirth, T. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1280 · Cited by 168
NF- B constitutes a potential therapeutic target in high-risk myelodysplastic syndrome
Braun, T., Carvalho, G., Coquelle, A., Vozenin, M.-C., Lepelley, P., Hirsch, F., Kiladjian, J.-J., Ribrag, V., Fenaux, P., & Kroemer, G. (2005) · Blood · doi:10.1182/blood-2005-05-1989 · Cited by 166
The NFκB pathway and endocrine-resistant breast cancer
Zhou, Y., Eppenberger-Castori, S., Eppenberger, U., & Benz, C. C. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00977 · Cited by 166
IKKα Regulates Mitogenic Signaling through Transcriptional Induction of Cyclin D1 via Tcf
Albanese, C., Wu, K., D’Amico, M., Jarrett, C. R., Joyce, D. A., Hughes, J. R., Hulit, J., Sakamaki, T., Fu, M., Ben‐Ze'ev, A., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-06-0101 · Cited by 165
Ueda, Y., & Richmond, A. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00304.x · Cited by 163
Tanaka, A. (2005) · Blood · doi:10.1182/blood-2004-08-3247 · Cited by 162
Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600608 · Cited by 162
Wang, W., Abbruzzese, J. L., Evans, D. B., & Chiao, P. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202833 · Cited by 161
Ni, H., Ergin, M., Huang, Q., Qin, J., Amin, H. M., Martinez, R. L., Saeed, S., Barton, K., & Alkan, S. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03102.x · Cited by 159
Nakshatri, H., Rice, S. E., & Bhat‐Nakshatri, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207995 · Cited by 159
Tai, Y.-T., Li, X., Tong, X., Santos, D., Otsuki, T., Catley, L., Tournilhac, O., Podar, K., Hideshima, T., Schlossman, R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4125 · Cited by 158
Robe, P. A. J. T., Bentires‐Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.-T. N., Jolois, O., Erkmen, K., Merville, M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0392 · Cited by 157
Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation
Nadiminty, N., Lou, W., Lee, S. O., Lin, X., Trump, D. L., & Gao, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509808103 · Cited by 147
Zhou, H., Du, M., & Dixit, V. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.012 · Cited by 145
Frelin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1463 · Cited by 142
Mrowietz, U., Schwenk, U., Maune, S., Bartels, J., Küpper, M., Fichtner, I., Schröder, J., & Schadendorf, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690164 · Cited by 137
Chen, G., Bhojani, M. S., Heaford, A. C., Chang, D. C., Laxman, B., Thomas, D. G., Griffin, L. B., Yu, J. B., Coppola, J. M., Giordano, T. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500397102 · Cited by 136
NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK
Zhang, J. Y., Green, C. L., Tao, S., & Khavari, P. A. (2004) · Genes & Development · doi:10.1101/gad.1160904 · Cited by 135
Arsura, M., Mercurio, F., Oliver, A. L., Thorgeirsson, S. S., & Sonenshein, G. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5381-5391.2000 · Cited by 134
Dying for NF-κB? Control of cell death by transcriptional regulation of the apoptotic machinery
Burstein, E., & Duckett, C. S. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.005 · Cited by 128
Role of inflammation in pancreatic carcinogenesis and the implications for future therapy
Garcea, G., Dennison, A. R., Steward, W. P., & Berry, D. P. (2005) · Pancreatology · doi:10.1159/000087493 · Cited by 128
Eddy, S. F., Guo, S., Demicco, E. G., Romieu, R., Landesman‐Bollag, E., Seldin, D. C., & Sonenshein, G. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1602 · Cited by 127
Nucleolar Sequestration of RelA (p65) Regulates NF-κB-Driven Transcription and Apoptosis
Stark, L. A., & Dunlop, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5985-6004.2005 · Cited by 127
The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance
Cilloni, D., Messa, F., Arruga, F., Defilippi, I., Morotti, A., Messa, E., Carturan, S., Giugliano, E., Pautasso, M., Bracco, E., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403998 · Cited by 123
Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors
Romieu, R., Kim, D. W., Shin, S. M., Demicco, E. G., Landesman‐Bollag, E., Seldin, D. C., Cardiff, R. D., & Sonenshein, G. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5738-5754.2003 · Cited by 119
Müerköster, S. S., Arlt, A., Sipos, B., Witt, M., Großmann, M., Klöppel, G., Kalthoff, H., Fölsch, U. R., & Schäfer, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1626 · Cited by 116
Niu, J., Li, Z., Peng, B., & Chiao, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309789200 · Cited by 110
Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation
Hammerman, P. S., Fox, C. J., Cinalli, R. M., Xu, A., Wagner, J. D. O., Lindsten, T., & Thompson, C. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2284 · Cited by 103
Ashikawa, K., Shishodia, S., Fokt, I., Priebe, W., & Aggarwal, B. B. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.039 · Cited by 97
Small, G. W., Shi, Y., Edmund, N. A., Somasundaram, S., Moore, D. T., & Orlowski, R. Z. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.003400 · Cited by 97
Ho, W. C., Dickson, K. M., & Barker, P. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3494 · Cited by 95
Mechanisms of Bcr-Abl-mediated NF-κB/Rel activation
Kirchner, D., Duyster, J., Ottmann, O. G., Schmid, R. M., Bergmann, L., & Munzert, G. M. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00069-9 · Cited by 94
Susceptibility of Cholangiocarcinoma Cells to Parthenolide-Induced Apoptosis
Kim, J., Liu, L., Lee, S. O., Kim, Y., You, K.-R., & Kim, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4193 · Cited by 92
García, M. G., Alaniz, L. D., Lopes, E. C., Blanco, G. A. C., Hajos, S. E., & Álvarez, É. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.05.004 · Cited by 91
Increased IκB kinase activity is associated with activated NF-κB in acute myeloid blasts
Baumgartner, B., Weber, M., Quirling, M., Fischer, C., Page, S., Adam, M., von Schilling, C., Waterhouse, C., Schmid, C., Neumeier, D., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402641 · Cited by 88
Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro
Subhashini, J., Mahipal, S. V. K., & Reddanna, P. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.002 · Cited by 87
Nasr, R., El-Sabban, M. E., Karam, J.-A., Dbaibo, G. S., Kfoury, Y. S., Arnulf, B., Lepelletier, Y., Bex, F., de Thé, H., Hermine, O., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208212 · Cited by 84
Huang, S., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · Cytokines Cellular & Molecular Therapy · doi:10.1080/13684730050515868 · Cited by 79
Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin
Singh, R. K., Varney, M. L., Bucana, C. D., & Johansson, S. L. (1999) · Melanoma Research · doi:10.1097/00008390-199908000-00007 · Cited by 78
Apoptosis Induction by a Novel Retinoid-Related Molecule Requires Nuclear Factor-κB Activation
Farhana, L., Dawson, M. I., & Fontana, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4124 · Cited by 70
DNA microarrays in breast cancer: the promise of personalised medicine
Ramaswamy, S., & Perou, C. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13322-3 · Cited by 67
Proteasome inhibition in hematologic malignancies
Richardson, P. G. G., Hideshima, T., Mitsiades, C. S., & Anderson, K. C. (2004) · Annals of Medicine · doi:10.1080/07853890410030877 · Cited by 66
Ostrander, J. H., Hawke, N. A., Kashatus, D. F., & Baldwin, A. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3898 · Cited by 52
Self-citationMEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation
Nawata, R., Yujiri, T., Nakamura, Y., Ariyoshi, K., Takahashi, T., Satō, Y., Oka, Y., & Tanizawa, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206901 · Cited by 45
Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IκBβ
Jiang, Y., Cui, L., Yie, T.-A., Rom, W. N., Cheng, H., & Tchou-Wong, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204293 · Cited by 41
Schneider, G., Weber, A. P. M., Zechner, U., Oswald, F., Frieß, H., Schmid, R. M., & Liptay, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21637 · Cited by 40
Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene Expression
Palmby, T. R., Abe, K., Karnoub, A. E., & Der, C. J. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.702.2.12 · Cited by 26
Rajkumar, S. V. (2003) · Seminars in Hematology · doi:10.1053/j.seminhematol.2003.09.007 · Cited by 18
Cited by
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Introduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,222
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
Metadata
- Authors
- Bassères, D. S., & Baldwin, A. S.
- Venue
- Oncogene
- Published
- 2006-10-30
- Volume
- 25
- Issue
- 51
- Pages
- 6817-6830
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1581923494
- Cited by
- 667
- References
- 142
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.